99% Savings - Buy Just @1 Rs X
Ozomet PG 2 Tablet ER (15) is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Diabetes. Ozomet PG 2 Tablet ER (15) also has some secondary and off-label uses. These are listed below.
The correct dosage of Ozomet PG 2 Tablet ER (15) depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Ozomet PG 2 Tablet ER (15) are Nausea or vomiting, Diarrhoea, Headache. Some other side effects of Ozomet PG 2 Tablet ER (15) have been listed ahead. These side effects of Ozomet PG 2 Tablet ER (15) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Ozomet PG 2 Tablet ER (15)'s effect during pregnancy is Unknown and Safe while nursing. In addition, Ozomet PG 2 Tablet ER (15)'s effects on the liver, heart and kidney are discussed below in the Ozomet PG 2 Tablet ER (15) related warnings section.
Individuals suffering from medical conditions like Liver Disease, Kidney Disease must refrain from the use of Ozomet PG 2 Tablet ER (15) since this can cause severe adverse effects.
Drug interactions for Ozomet PG 2 Tablet ER (15) have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Ozomet PG 2 Tablet ER (15) is not safe while driving, and is is not addictive in nature.
Ozomet PG 2 Tablet ER (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ozomet PG 2 Tablet ER (15) safe for pregnant women?
No research has not been done till date on the safety of Ozomet PG for pregnant women. So its effects on pregnant women are unknown.
Is the use of Ozomet PG 2 Tablet ER (15) safe during breastfeeding?
Ozomet PG does not show any harmful effects in lactating women.
What is the effect of Ozomet PG 2 Tablet ER (15) on the Kidneys?
Ozomet PG can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ozomet PG 2 Tablet ER (15) on the Liver?
The liver can be affected by Ozomet PG. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Ozomet PG only after medical advice.
What is the effect of Ozomet PG 2 Tablet ER (15) on the Heart?
Ozomet PG is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Ozomet PG 2 Tablet ER (15) unless your doctor advises you to do so -
Is this Ozomet PG 2 Tablet ER (15) habit forming or addictive?
Ozomet PG 2 Tablet ER (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Ozomet PG 2 Tablet ER (15). So it is best to avoid driving.
Is it safe?
Yes, Ozomet PG 2 Tablet ER (15) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Ozomet PG 2 Tablet ER (15) for mental disorders.
Interaction between Food and Ozomet PG 2 Tablet ER (15)
Due to the absence of research, it is difficult to say how Ozomet PG 2 Tablet ER (15) and food will interact.
Interaction between Alcohol and Ozomet PG 2 Tablet ER (15)
No research has been done on this till date. Therefore, it is not known what the effect of taking Ozomet PG 2 Tablet ER (15) with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033